Quantcast

Latest Genentech Inc. Stories

2006-08-29 08:24:22

By Sam Cage ZURICH (Reuters) - Drugmaker Novartis AG said on Tuesday that Switzerland had become the first European country to approve the company's Lucentis drug as a treatment for a leading cause of blindness in people over age 50. The U.S.

2006-08-29 05:04:54

By Sam Cage ZURICH (Reuters) - Drugmaker Novartis AG said on Tuesday that Switzerland had become the first European country to approve the company's Lucentis drug as a treatment for a leading cause of blindness in people over age 50. The U.S.

2006-08-28 08:20:23

CHICAGO (Reuters) - Biotechnology companies Genentech Inc. and Biogen Idec Inc. said on Monday cancer drug Rituxan was successful at treating multiple sclerosis in a midstage trial.

2006-06-30 19:20:42

By Lisa Richwine WASHINGTON (Reuters) - A Genentech Inc. drug that reversed vision loss in some patients won U.S. approval on Friday for treating the leading cause of blindness in the elderly.

2005-11-14 14:33:08

LOS ANGELES (Reuters) - Genentech Inc. and Biogen Idec Inc.'s cancer drug Rituxan improved symptoms of rheumatoid arthritis in patients not helped by drugs designed to block an inflammation-causing protein, researchers said on Sunday.

2005-10-19 07:19:29

CHICAGO (Reuters) - Genentech Inc. said on Tuesday early results from a mid-stage trial show that combining lung cancer drug Tarceva with Avastin works no better than Avastin alone in patients with advanced kidney cancer, sending shares of Tarceva partner OSI Pharmaceuticals Inc. down 7 percent.

2005-07-20 10:47:03

WASHINGTON (Reuters) - Genentech Inc. and U.S. regulators have added a warning about the risk of a certain type of anemia with the biotech company's Raptiva drug for psoriasis, according to a letter made public on Wednesday.

2005-07-18 11:59:19

NEW YORK (Reuters) - Genentech Inc. on Monday said the average patient with age-related macular degeneration who received its experimental drug Lucentis could read an additional seven letters of a reading chart, compared with a vision loss of 10.5 letters among those who received sham injections.

1f81ecc5ad08acab842b7a7fd3089a5e1
2004-11-29 15:00:00

Genentech Inc. said Monday its novel colon cancer-fighting drug Avastin helped some of the sickest patients stay alive two months longer than expected, giving the drug an additional boost on its way to blockbuster status.

2004-11-29 12:00:19

SOUTH SAN FRANCISCO, Calif. and BASEL, Switzerland, Nov. 29 /PRNewswire-FirstCall/ -- Genentech, Inc.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related